Asia-Pacific Lab Automation Market – Industry Trends and Forecast to 2029

Asia-Pacific Lab Automation Market Analysis and Insights

The demand for the lab automation market is increasing due to the advancement of technology all around the world. For the healthcare sector lab automation equipment and tools are used. As healthcare expenditure has become higher due to several factors, the leading pharma & healthcare companies have to automate the labs to deliver advanced healthcare services at the doorstep within less time.

The growing healthcare demand in the market is the main cause of competition between the leading healthcare and pharma companies in the improvement of lab automation worldwide. The rise in the use of equipment, analyzer and software for the lab has been used. The focus for the market players is to provide variability of tools, equipment, machines and techniques to support the development and manufacturing of automated laboratory infrastructure. Market players are coming up with more investments and funding to build advanced technology and methods.

Healthcare expenditure has become higher due to several factors, such as the aging population, chronic disease prevalence, rising drug prices, healthcare service costs and administrative costs among others. Moreover, hospitals, private labs, clinical research and diagnostics centers are rising, increasing the lab automation market demand.

Asia-Pacific lab automation market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.6% in the forecast period of 2022 to 2029 and is expected to reach USD 2,863.27 million by 2029.

Market Definition

Laboratory automation is the combination of automated technologies in the laboratory to enable new and improved processes. It is used as a strategy to research, develop, optimize and capitalize on technologies in the laboratory. It is specially used for automating laboratory processes requiring minimal human input and eliminating human error. Lab automation is used with the aim of providing more efficient testing and diagnostics.

Lab automation enables researchers and technicians to efficiently and effectively produce output in less time, which is expected to drive the lab automation market. Furthermore, the rapid spread of diseases, along with new discoveries in the field of healthcare, ascend the demand for diagnoses and treatments, which is expected to fuel the lab automation market. High government and private funding for research and discovery research and the presence of major market players also contribute to the market growth.

Lab Automation Market Dynamics

Drivers

• Increasing investment & strategic initiatives by market players

The market for laboratory automation is increasing as there is high demand for specialized advanced automated services which eliminate human errors. The focus of the market players and the companies is to provide a variability of tools, equipment, machines and techniques to support the development and manufacturing of automated laboratory infrastructure. The market for laboratory automation is increasing as there is high demand for specialized advanced automated services which eliminate human error. In order to capture the global market share, the market players are coming up with more investments and funding to build advanced technology and methods. These players are more focused on reducing manual efforts and hands-on time for the traditionally labor-intensive process. This is expected to drive the market's growth.

• Government initiatives to strengthen laboratory infrastructures

In order to further strengthen the healthcare sector and laboratory infrastructure, government organizations play a significant role. The government's funding and initiative to expand laboratory automation will help the market growth and increase the market players. The government collaborations and agreements with the market's key players will further strengthen the laboratory infrastructure.

• Growing expenditure on lab automation tools and equipment

The growing expenditure on lab automation tools and equipment is increasing. This is mainly due to the demand for laboratory examinations increasing rapidly for various reasons, such as an aging population, chronic disease growth, the discovery of new and more effective biomarkers and an increase in general health or diagnostic demands.

• Reducing human efforts and eliminating human error

There are several traditional ways to reduce human errors, but developing a system to minimize the risk of human error will help ensure that you don't repeat the same mistakes again. Manufacturing facilities are focused on building advanced systems in order to utilize artificial intelligence technology to recognize and correct issues before they occur.

Opportunities

• Rising healthcare expenditure

Healthcare expenditure has become higher due to several factors, such as the aging population, chronic disease prevalence, rising drug prices, healthcare service costs and administrative costs among others. However, 2020 was the turning point where the expenses ranked the highest due to the COVID-19 pandemic. It has been found that in 2020, healthcare expenditure grew at the fastest rate of growth experienced since 2002 due to the pandemic.

• Strategic initiatives by key players

Various initiatives have been taken by the leading pharma & healthcare companies to automate the labs to deliver advanced healthcare services to the doorstep within less time. The growing healthcare demand in the market is the main cause of competition between the leading healthcare & pharma companies in the improvement of lab automation worldwide. Hence, the strategic initiatives by market players are expected to act as an opportunity for the lab automation market's growth.

• Rise in the number of pharma companies

The pharmaceutical industry has experienced significant growth during the past two decades. Growing disposable incomes, increased access to healthcare facilities, growing consciousness towards healthcare among people and increased penetration of medical services are making the pharma companies rise in number to fulfill the demand.

The COVID-19 pandemic had a great impact on the pharmaceutical industry because of the increased demand for medical services and drug supplies. Pharma industries have been growing fastly worldwide to fulfill the high demand of mankind and hence the service should be delivered at the earliest. So, to achieve error-free fast serving advanced healthcare facilities within less time, lab automation is needed. Thus, the rise in the number of pharma companies is expected to act as an opportunity for the lab automation market growth.

Restraints/Challenges

• Limitation analyzing novel complex product

There are various factors that contribute to the complexity of novel products used in automated laboratories. The continued engagement between staff and device manufacturers early in the development process is much needed and becomes mandatory to understand in order to operate the part or overall setup. Limitations in the detection and analysis of novel complex products such as machines, tools and equipment are hampering the installation and working of automated labs in the market.

• High cost for installation and setup

Lab automation installation and setup are much more labor-intensive and complex procedures. The setting up of automated labs requires a lot of time, effort, planning, implementation and approvals from various government departments. Moreover, the essential thing for setting up a new lab requires a critical investment in infrastructure due to the high cost of advanced machines, tools and equipment.

• Upgradation, maintenance and periodical checkups

Operating labs efficiently is the primary concern after setup. The maintenance, up-gradation and periodical checkups of equipment are necessary for the operation. The expense that is required for this is one of the main restraining factors for the market players. The laboratory holders are made mandatory by regulation or quality control to test their products irrespective of the manufacturing companies in order to operate smoothly and avoid circumstances. This may restrain the market growth.

Post-COVID-19 Impact on the Lab Automation Market

COVID-19 has positively affected the automation market. Due to the pandemic, people health has been affected, due to which high diagnostic tests happened and demand got increased. Private labs, hospitals and clinical research got increased due to the pandemic. Thus, COVID-19 increased the lab automation market positively.

Recent Developments

• In June 2022, BD announced that they had completed the acquisition of Straub Medical AG, a privately held company. With this acquisition, the company has added the valuable expertise and experience of Straub Medical AG and expanded its product portfolio
• In January 2022, QIAGEN announced that it has entered into new collaborations with Atlia Biosystems to provide non-invasive prenatal testing solutions.

Asia-Pacific Lab Automation Market Scope

Asia-Pacific lab automation market is segmented into product type, automated systems, application, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product Type

• Equipment
• Analyzer
• Software & Informatics

Based on product type, the Asia-Pacific lab automation market is segmented into equipment, analyzer, and software and informatics.

Automated Systems

• Total Lab Automation
• Modular Lab Automation

Based on automated systems, the Asia-Pacific lab automation market is segmented into total lab automation and modular lab automation.

Application

• Clinical Diagnostics
• Drug Discovery
• Genomics Solutions
• Proteomic Solutions
• Analytical Chemistry
• Protein Engineering
• Lyophilization
• Bio Analysis
• System Biology
• Others

Based on application, the Asia-Pacific lab automation market is segmented into drug discovery, clinical diagnostics, genomic solutions, proteomic solutions, bio analysis, protein engineering, lyophilization, system biology, analytical chemistry, and others.

 End User

• Biotechnology And Pharmaceuticals
• Hospitals & Laboratories
• Research And Academic Institutes
• Others

Based on end user, the Asia-Pacific lab automation market is segmented into biotechnology & pharmaceuticals, hospitals & laboratories, research and academic institutions, and others.

Asia-Pacific Lab Automation Market Regional Analysis/Insights

Asia-Pacific lab automation market is analyzed, and market size insights and trends are provided by country, product type, automated systems, application, and end user.

Countries covered in market are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.

China is expected to dominate the Asia-Pacific lab automation market due to a growing number of research activities along with the prevalence of various pharmaceutical companies. An increase in demand for equipment, analyzer, and software is expected to drive the regional market in the forecasted period.

The region section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Central America brands and their challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Asia-Pacific Lab Automation Market Share Analysis

The lab automation market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the Asia-Pacific lab automation market.

Some of the major players operating in the Asia-Pacific lab automation market are QIAGEN, Siemens Healthcare, F. Hoffman Roche, Hamilton Company, Hudson Robotics, LabVantage Solutions Inc., Abbott, BD, BIOMERIEUX, Aurora Biomed Inc., Danaher, Tecan Trading AG, PerkinElmer Inc, Thermo Fisher Scientific, Agilent Technologies, Azenta US Inc, Eppendorf SE, and Labware among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by the DBMR research team is data triangulation which involves data mining, analysis of the Impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include a Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Asia-Pacific vs. Regional and Vendor Share Analysis. Please request an analyst call in case of further inquiry.

SKU-50084